[1] WRÍBEL M P,MAREK B,KAIDANIUK D,et al.Metformin-a new old drug[J].Endokrynol Pol,2017,68(4):482-496.
[2] ASSOCIATION A D.Standards of medical care in diabetes-2012[J].Diabetes Care,2012,35(Suppl 1):S11-S63.
[3] LU J,WENG J,JI N,et al.China guideline for type 2 diabetes[J].Diabetes,2011,104(1):1-52.
[4] International Diabetes Federation Guideline Development Group.Global guideline for type 2 diabetes[J].Diabetes Res Clin Pract,2014,104(1):1-52.
[5] IDF Clinical Guidelines Task Force.Global guideline for type 2 diabetes:Recommendations for standard,comprehensive,and minimal care[J].Diabetic Med,2006,23(6):579-593.
[6] BLONDE L,ROSENSTOCK J,MOORADIAN A D,et al.Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy[J].Diabetes Obes Metab,2002,4(6):368-375.
[7] WANG W,BU R,SU Q,et al.Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy[J].Expert Opin Pharmacother,2011,12(18):2791-2799.
[8] FONSECA V,ROSENSTOCK J,PATWARDHAN R,et al.Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus:a randomized controlled trial[J].JAMA,2000,283(13):1695-1702.
[9] 韦诚,罗丽艳.阿卡波糖联合盐酸二甲双胍治疗2型糖尿病的效果探析[J].当代医药论丛,2017(16):96-97.
[10] 马培,徐焱成,胡元,等.二甲双胍联合DPP4抑制剂或磺脲类药物疗效与安全性的Meta分析[J].实用医学杂志,2015,31(10):1688-1691.
[11] 李吉,孙家忠,李广森,等.SGLT2抑制剂联合二甲双胍治疗2型糖尿病的安全性和有效性的Meta分析[J].武汉大学学报:医学版,2014,35(6):969-975.
[12] STROWIG S M,AVILES-SANTA M L,RASKIN P.Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes[J].Diabetes Care,2002,25(10):1691-1698.
[13] 杨晶晶,王宝佳.二甲双胍肠溶片致消化道溃疡1例[J].西南军医,2007,9(2):21.
[14] SALPETER S R,GREYBER E,PASTEMAK G A,et al.Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus[J].Cochrane Database Syst Rev,2010,163(1):CD002967.
[15] SAHIN M,TUTUNCY N B,ERTUGRUL D,et al.Effects of metformin or rosiglitazone on serum concentrations of homocysteine,folate,and vitamin B12 in patients with type 2 diabetes mellitus[J].J Diabetes,2007,21(2):118-123.
[16] LIU K W,DAI L K,JEAN W.Metformin-related vitamin B12 deficiency[J].Age Ageing,2006,35(2):200-201.
[17] ALSUBAIE S,ALMALKI M H.Metformin induced acute pancreatitis[J].Dermatoendocrinol,2013,5(2):317-318.
[18] 苏娜,徐珽,唐尧.二甲双胍致不良反应的文献分析[J].华西医学,2011(11):1608-1610.
[19] ONG C R,MOLYNEAUX L M,CONSTANTINO M I,et al.Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes[J].Diabetes Care,2006,29(11):2361-2364.
[20] ITO H,ISHIDA H,TAKEUCHI Y,et al.Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus[J].Nutr Metab,2010,7(1):1-9.
[21] JI L,LI H,GUO X,et al.Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients:phase Ⅳ open-label trial[J].Plos One,2013,8(2):269-284.
[22] 佟莉,帅宁安,陆放,等.二甲双胍在不同体重指数新诊断2型糖尿病患者多项目临床观察[J].中国医学创新,2016,13(13):123-126.
[23] 蒋翠萍,黄宇新,孙皎.不同体质指数对于老年2型糖尿病患者服用二甲双胍胃肠道不良反应的影响[J].老年医学与保健,2016,22(1):44-47.
[24] GUO L,GUO X,LI Y,et al.Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes:sub-analysis of a phase Ⅳ open-label trial in Chinese patients[J].Diabetes Metab Syndr,2016,10(3):137-142.
[25] 杨光,李春霖,田慧,等.非肥胖老年2型糖尿病患者使用二甲双胍的疗效及安全性[J].中华老年多器官疾病杂志,2010,9(5):417-420. |
